公开(公告)号：US11820835B2

公开(公告)日：2023-11-21

申请号：US16982638

申请日：2019-03-22

申请人： University of Kansas ,  UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.

发明人： Jane Aldrich ,  Sanjeewa Senadheera ,  Jay McLaughlin

IPC分类号： C07K5/12 ,  A61K9/00 ,  A61K38/00

CPC分类号： C07K5/126 ,  A61K9/0053 ,  A61K38/00

摘要： The present technology provides compounds of Formula I (or pharmaceutically acceptable salts and/or solvates thereof) that are useful in treating a CNS-related disorder such as schizophrenia, schizoaffective disorder, migraine, depression, pain, drug addiction, drug use, and/or drug seeking behavior. Also provided are compositions, medicaments, and methods including such compounds.

公开(公告)号：US20210024576A1

公开(公告)日：2021-01-28

申请号：US16982638

申请日：2019-03-22

申请人： University of Kansas ,  University of Florida

发明人： Jane Aldrich ,  Sanjeewa Senadheera ,  Jay McLaughlin

IPC分类号： C07K5/12 ,  A61K38/00 ,  A61K9/00

摘要： The present technology provides compounds of Formula I (or pharmaceutically acceptable salts and/or solvates thereof) that are useful in treating a CNS-related disorder such as schizophrenia, schizoaffective disorder, migraine, depression, pain, drug addiction, drug use, and/or drug seeking behavior. Also provided are compositions, medicaments, and methods including such compounds.